Stifel Nicolaus Increases Trupanion (NASDAQ:TRUP) Price Target to $29.00

Trupanion (NASDAQ:TRUP) had its target price increased by equities researchers at Stifel Nicolaus from $28.00 to $29.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “hold” rating on the financial services provider’s stock. Stifel Nicolaus’ price objective indicates a potential downside of 6.75% from the stock’s current price.

Other research analysts have also issued research reports about the company. Atlantic Securities set a $42.00 price objective on Trupanion in a research report on Wednesday, July 15th. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Finally, Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and a consensus target price of $41.80.

Trupanion Price Performance

Shares of NASDAQ:TRUP opened at $31.10 on Thursday. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 58.68, a P/E/G ratio of 2.07 and a beta of 1.39. The firm has a fifty day moving average price of $26.03 and a 200 day moving average price of $26.03. Trupanion has a fifty-two week low of $21.16 and a fifty-two week high of $48.48. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.22 EPS. As a group, sell-side analysts expect that Trupanion will post 0.61 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, COO John R. Gallagher sold 3,603 shares of Trupanion stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the completion of the sale, the chief operating officer directly owned 33,065 shares in the company, valued at $717,179.85. The trade was a 9.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president directly owned 78,062 shares of the company’s stock, valued at $1,717,364. The trade was a 7.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 18,785 shares of company stock worth $422,862. 5.58% of the stock is currently owned by company insiders.

Institutional Trading of Trupanion

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Trupanion in the second quarter valued at approximately $134,774,000. Bank of America Corp DE purchased a new position in shares of Trupanion during the 2nd quarter valued at approximately $14,262,000. Millennium Management LLC grew its stake in Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after acquiring an additional 402,421 shares during the period. Renaissancere Holdings Ltd. purchased a new stake in Trupanion in the 2nd quarter worth $6,514,510,000. Finally, Goldman Sachs Group Inc. increased its holdings in Trupanion by 116.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock worth $17,826,000 after acquiring an additional 256,559 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.